Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
—
Employees—
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
—
Employees—

ASND Key Statistics

Market cap
14.82B
Market cap14.82B
Price-Earnings ratio
16.27
Price-Earnings ratio16.27
Dividend yield
—
Dividend yield—
Average volume
1.15M
Average volume1.15M
High today
—
High today—
Low today
—
Low today—
Open price
$230.13
Open price$230.13
Volume
0.00
Volume0.00
52 Week high
$282.15
52 Week high$282.15
52 Week low
$186.05
52 Week low$186.05

Stock Snapshot

Ascendis Pharma A/S(ASND) stock is priced at $225.60, giving the company a market capitalization of 14.82B. It carries a P/E multiple of 16.27.

During the trading day, Ascendis Pharma A/S(ASND) stock saw an opening price of $230.13, a peak of —, and a bottom of —.

Trading volume for Ascendis Pharma A/S(ASND) stock has reached 0, versus its average volume of 1.15M.

Over the past 52 weeks, Ascendis Pharma A/S(ASND) stock has traded between a high of $282.15 and a low of $186.05.

Over the past 52 weeks, Ascendis Pharma A/S(ASND) stock has traded between a high of $282.15 and a low of $186.05.

ASND News

Simply Wall St 2d
Ascendis Pharma Could Be 28% Undervalued As It Reclaims TransCon Rights

Ascendis Pharma (NasdaqGS:ASND) has just taken full control of its TransCon technology in metabolic and cardiovascular diseases after ending its collaboration w...

Ascendis Pharma Could Be 28% Undervalued As It Reclaims TransCon Rights

Analyst ratings

100%

of 21 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.